Comparison of 1000 Hertz (Hz), Burst, and Standard Spinal Cord Stimulation in Chronic Pain Relief
Unknown statusPhase 2, Phase 3NCT02902796
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
A randomized controlled with cross over study compares efficacy of burst stimulation, 1000 hertz stimulation, and standard stimulation in an non-superiority trial. The study duration is approximately 24 weeks and each stimulation modes will last for approximately 3 weeks with approximately 4 days of wash off in between.
Study details
- Official title
- Randomized Controlled Cross Over Study to Compare the Efficacy of 1000 Hertz (Hz), Burst, and Standard Spinal Cord Stimulation in Chronic Axial Pain Relief
- Conditions
- Interventions
- Sponsor
- The Center for Clinical Research, Winston-Salem, NC
- Start date
- 2016-09
- Primary completion
- 2019-09
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Subject must be 18 years and older, and younger than 75 years of age. * Subject has had a Precision Spectra, or Plus spinal cord stimulator system implanted for chronic painful condition. * Subject continues to receive adequate pain relief with greater than or equal to 50% pain relief based on pre-trial and pre-implant pain assessment. * Device age should not be less than 2 months old. * Subject is willing to comply with all requirements of the study. Exclusion Criteria: * Subjects who are getting \<50% pain relief on current SCS based on pre-trial and pre-implant pain assessment. * Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain * Unstable medical or psychiatric illness * Urine drug screen shows controlled substance/s not prescribed by the prescribers. * Lifetime history of psychosis, hypomania, or mania. * Epilepsy, or dementia * Substance abuse in the last 6 months * Pregnant or breastfeeding * Not on contraception for those of childbearing age. (Barrier methods, oral contraception, hormone injections, or surgical sterilization) * Treatment with investigational drug within 30 days of screening.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02902796